Cellular and Molecular Basis of Intestinal Barrier Dysfunction in the Irritable Bowel Syndrome

키워드

참고문헌 (87)

1. Turner JR, "Intestinal mucosal barrier function in health and disease", Nat Rev Immunol, 9, pp.799~809 (2009)
2. Laurie Glimcher, "Homeostasis and Inflammation in the Intestine", CELL, 140(6), pp.859~870, CELL PRESS
3. Mayer EA, "The brain-gut axis in abdominal pain syndromes", Annu Rev Med, 62, pp.381~396 (2011)
4. Dunlop SP, "Abnormal intestinal permeability in subgroups of diarrhea-predominant irritable bowel syndromes", Am J Gastroenterol, 101, pp.1288~1294 (2006)
5. Zhou Q, "Intestinal membrane permeability and hypersensitivity in the irritable bowel syndrome", Pain, 146, pp.41~46 (2009)
6. Spiller RC, "Increased rectal mucosal enteroendocrine cells, T lymphocytes, and increased gut permeability following acute Campylobacter enteritis and in post-dysenteric irritable bowel syndrome", Gut, 47, pp.804~811 (2000)
7. Marshall JK, "Intestinal permeability in patients with irritable bowel syndrome after a waterborne outbreak of acute gastroenteritis in Walkerton, Ontario", Aliment Pharmacol Ther, 20, pp.1317~1322 (2004)
8. Gwee KA, "Increased rectal mucosal expression of interleukin 1beta in recently acquired post-infectious irritable bowel syndrome", Gu, 52, pp.523~526 (2003)
9. Chadwick VS, "Activation of the mucosal immune system in irritable bowel syndrome", Gastroenterology, 122, pp.1778~1783 (2002)
10. Guilarte M, "Diarrhoea-predominant IBS patients show mast cell activation and hyperplasia in the jejunum", Gut, 56, pp.203~209 (2007)
11. Piche T, "Impaired intestinal barrier integrity in the colon of patients with irritable bowel syndrome: involvement of soluble mediators", Gut, 58, pp.196~201 (2009)
12. Coeffier M, "Increased proteasome-mediated degradation of occludin in irritable bowel syndrome", Am J Gastroenterol, 105, pp.1181~1188 (2010)
13. Martínez C, "The jejunum of diarrhea-predominant irritable bowel syndrome shows molecular alterations in the tight junction signaling pathway that are associated with mucosal pathobiology and clinical manifestations", Am J Gastroenterol, 107, pp.736~746 (2012)
14. Johansson ME, "The inner of the two Muc2 mucin-dependent mucus layers in colon is devoid of bacteria", Proc Natl Acad Sci U S A, 105, pp.15064~15069 (2008)
15. Bevins CL, "Paneth cells, antimicrobial peptides and maintenance of intestinal homeostasis", Nat Rev Microbiol, 9, pp.356~368 (2011)
16. Macpherson AJ, "The immune geography of IgA induction and function", Mucosal Immunol, 1, pp.11~22 (2008)
17. Salzman NH, "Enteric defensins are essential regulators of intestinal microbial ecology", Nat Immunol, 11, pp.76~83 (2010)
18. Marques R, "Expression and functional importance of innate immune receptors by intestinal epithelial cells", Cell Mol Life Sci, 68, pp.3661~3673 (2011)
19. Rescigno M, "The intestinal epithelial barrier in the control of homeostasis and immunity", Trends Immunol, 32, pp.256~264 (2011)
20. Shen L, "Actin depolymerization disrupts tight junctions via caveolae-mediated endocytosis", Mol Biol Cell, 16, pp.3919~3936 (2005)
21. Saitou M, "Complex phenotype of mice lacking occludin, a component of tight junction strands", Mol Biol Cell, 11, pp.4131~4142 (2000)
22. Saitou M, "Occludin-deficient embryonic stem cells can differentiate into polarized epithelial cells bearing tight junctions", J Cell Biol, 141, pp.397~408 (1998)
23. Rao R, "Occludin phosphorylation in regulation of epithelial tight junctions", Ann N Y Acad Sci, 1165, pp.62~68 (2009)
24. Simonovic I, "Enteropathogenic Escherichia coli dephosphorylates and dissociates occludin from intestinal epithelial tight junctions", Cell Microbiol, 2, pp.305~315 (2000)
25. Kale G, "Tyrosine phosphorylation of occludin attenuates its interactions with ZO-1, ZO-2, and ZO-3", Biochem Biophys Res Commun, 302, pp.324~329 (2003)
26. Van Itallie CM, "Claudins and epithelial paracellular transport", Annu Rev Physiol, 68, pp.403~429 (2006)
27. Cereijido M, "Tight junction and polarity interaction in the transporting epithelial phenotype", Biochim Biophys Acta, 1778, pp.770~793 (2008)
28. Fihn BM, "Permeability of the rat small intestinal epithelium along the villus-crypt axis: effects of glucose transport", Gastroenterology, 119, pp.1029~1036 (2000)
29. Schumann M, "Cell polarity-determining proteins Par-3 and PP-1 are involved in epithelial tight junction defects in coeliac disease", Gut, 61, pp.220~228 (2012)
30. Zeissig S, "Changes in expression and distribution of claudin 2, 5 and 8 lead to discontinuous tight junctions and barrier dysfunction in active Crohn’s disease", Gut, 56, pp.61~72 (2007)
31. Escaffit F, "Differential expression of claudin-2 along the human intestine: implication of GATA-4 in the maintenance of claudin-2 in differentiating cells", J Cell Physiol, 203, pp.15~26 (2005)
32. Tsukita S, "Roles of ZO-1 and ZO-2 in establishment of the belt-like adherens and tight junctions with paracellular permselective barrier function", Ann N Y Acad Sci, 1165, pp.44~52 (2009)
33. Umeda K, "ZO-1 and ZO-2 independently determine where claudins are polymerized in tight-junction strand formation", Cell, 126, pp.741~754 (2006)
34. Shen L, "Role of epithelial cells in initiation and propagation of intestinal inflammation. Eliminating the static: tight junction dynamics exposed", Am J Physiol Gastrointest Liver Physiol, 290, pp.G577~G582 (2006)
35. Utech M, "Endocytosis and recycling of tight junction proteins in inflammation", J Biomed Biotechnol, 2010, pp.484987~ (2010)
36. Schulzke JD, "Disrupted barrier function through epithelial cell apoptosis", Ann N Y Acad Sci, 1072, pp.288~299 (2006)
37. Turner JR, "Physiological regulation of epithelial tight junctions is associated with myosin light-chain phosphorylation", Am J Physiol, 273, pp.C1378~C1385 (1997)
38. Yuhan R, "Enteropathogenic Escherichia coli-induced myosin light chain phosphorylation alters intestinal epithelial permeability", Gastroenterology, 113, pp.1873~1882 (1997)
39. Marchiando AM, "Caveolin-1-dependent occludin endocytosis is required for TNF-induced tight junction regulation in vivo", J Cell Biol, 189, pp.111~126 (2010)
40. Teshima CW, "The measurement and clinical significance of intestinal permeability", Curr Gastroenterol Rep, 10, pp.443~449 (2008)
41. Albin DM, "Advances in methods to evaluate gastrointestinal transport function", Curr Opin Clin Nutr Metab Care, 4, pp.351~354 (2001)
42. Arrieta MC, "Alterations in intestinal permeability", Gut, 55, pp.1512~1520 (2006)
43. Camilleri M, "Intestinal permeability and irritable bowel syndrome", Neurogastroenterol Motil, 19, pp.545~552 (2007)
44. Gunnar M, "The neurobiology of stress and development", Annu Rev Psychol, 58, pp.145~173 (2007)
45. Chang L, "The role of stress on physiologic responses and clinical symptoms in irritable bowel syndrome", Gastroenterology, 140, pp.761~765 (2011)
46. Lydiard RB, "Irritable bowel syndrome, anxiety, and depression: what are the links?", J Clin Psychiatry, 62(Suppl 8), pp.38~45 (2001)
47. Dinan TG, "Hypothalamic-pituitary-gut axis dysregulation in irritable bowel syndrome: plasma cytokines as a potential biomarker?", Gastroenterology, 130, pp.304~311 (2006)
48. Santos J, "Corticotropin-releasing hormone mimics stress-induced colonic epithelial pathophysiology in the rat", Am J Physiol, 277(2 Pt 1), pp.G391~G399 (1999)
49. Santos J, "Chronic stress impairs rat growth and jejunal epithelial barrier function: role of mast cells", Am J Physiol Gastrointest Liver Physiol, 278, pp.G847~G854 (2000)
50. Vicario M, "Chronic psychosocial stress induces reversible mitochondrial damage and corticotropin-releasing factor receptor type-1 upregulation in the rat intestine and IBS-like gut dysfunction", Psychoneuroendocrinology, 37, pp.65~77 (2012)
51. Yates DA, "Adaptation of stress-induced mucosal pathophysiology in rat colon involves opioid pathways", Am J Physiol Gastrointest Liver Physiol, 281, pp.G124~G128 (2001)
52. Barclay GR, "Effect of psychological stress on salt and water transport in the human jejunum", Gastroenterology, 93, pp.91~97 (1987)
53. Santos J, "Release of mast cell mediators into the jejunum by cold pain stress in humans", Gastroenterology, 114, pp.640~648 (1998)
54. Alonso C, "Maladaptive intestinal epithelial responses to life stress may predispose healthy women to gut mucosal inflammation", Gastroenterology, 135, pp.163~172 (2008)
55. Iweala OI, "Immune privilege in the gut: the establishment and maintenance of non-responsiveness to dietary antigens and commensal flora", Immunol Rev, 213, pp.82~100 (2006)
56. Barbara G, "Activated mast cells in proximity to colonic nerves correlate with abdominal pain in irritable bowel syndrome", Gastroenterology, 126, pp.693~702 (2004)
57. Cenac N, "Role for protease activity in visceral pain in irritable bowel syndrome", J Clin Invest, 117, pp.636~647 (2007)
58. Barbara G, "Mast cell-dependent excitation of visceral-nociceptive sensory neurons in irritable bowel syndrome", Gastroenterology, 132, pp.26~37 (2007)
59. Buhner S, "Activation of human enteric neurons by supernatants of colonic biopsy specimens from patients with irritable bowel syndrome", Gastroenterology, 137, pp.1425~1434 (2009)
60. Cremon C, "Mucosal immune activation in irritable bowel syndrome: gender-dependence and association with digestive symptoms", Am J Gastroenterol, 104, pp.392~400 (2009)
61. Musch MW, "T cell activation causes diarrhea by increasing intestinal permeability and inhibiting epithelial Na+", K+-ATPase, 2002, pp.110, 1739~1747
62. Wang F, "Interferon-gamma and tumor necrosis factor-alpha synergize to induce intestinal epithelial barrier dysfunction by up-regulating myosin light chain kinase expression", Am J Pathol, 166, pp.409~419 (2005)
63. Bruewer M, "Interferon-gamma induces internalization of epithelial tight junction proteins via a macropinocytosis-like process", FASEB J, 19, pp.923~933 (2005)
64. Weber CR, "Epithelial myosin light chain kinase activation induces mucosal interleukin-13 expression to alter tight junction ion selectivity", J Biol Chem, 285, pp.12037~12046 (2010)
65. Wisner DM, "Opposing regulation of the tight junction protein claudin-2 by interferon-gamma and interleukin-4", J Surg Res, 144, pp.1~7 (2008)
66. Santos J, "Pathogenesis of irritable bowel syndrome: the mast cell connection", Scand J Gastroenterol, 40, pp.129~140 (2005)
67. Jacob C, "Mast cell tryptase controls paracellular permeability of the intestine. Role of protease-activated receptor 2 and beta-arrestins", J Biol Chem, 280, pp.31936~31948 (2005)
68. Galli SJ, "Immunomodulatory mast cells: negative, as well as positive, regulators of immunity", Nat Rev Immunol, 8, pp.478~486 (2008)
69. Wallon C, "Corticotropin-releasing hormone (CRH) regulates macromolecular permeability via mast cells in normal human colonic biopsies in vitro", Gut, 57, pp.50~58 (2008)
70. Kempuraj D, "Corticotropin-releasing hormone and its structurally related urocortin are synthesized and secreted by human mast cells", Endocrinology, 145, pp.43~48 (2004)
71. Barreau F, "Pathways involved in gut mucosal barrier dysfunction induced in adult rats by maternal deprivation: corticotrophin-releasing factor and nerve growth factor interplay", J Physiol, 580(Pt 1), pp.347~356 (2007)
72. Al-Sadi R, "Cellular and molecular mechanism of interleukin-1beta modulation of Caco-2 intestinal epithelial tight junction barrier", J Cell Mol Med, 15, pp.970~982 (2011)
73. Suzuki T, "Interleukin-6 (IL-6) regulates claudin-2 expression and tight junction permeability in intestinal epithelium", J Biol Chem, 286, pp.31263~31271 (2011)
74. O’Sullivan M, "Increased mast cells in the irritable bowel syndrome", Neurogastroenterol Motil, 12, pp.449~457 (2000)
75. Furuta GT, "Eosinophils alter colonic epithelial barrier function: role for major basic protein", Am J Physiol Gastrointest Liver Physiol, 289, pp.G890~G897 (2005)
76. Park KS, "A survey about irritable bowel syndrome in South Korea: prevalence and observable organic abnormalities in IBS patients", Dig Dis Sci, 53, pp.704~711 (2008)
77. Guilarte M, "Corticotropin-releasing hormone (CRH) triggers jejunal mast cell and eosinophil activation in IBS patients", Gastroenterology, 126(Suppl 2), pp.A38~ (2004)
78. Aerssens J, "Alterations in mucosal immunity identified in the colon of patients with irritable bowel syndrome", Clin Gastroenterol Hepatol, 6, pp.194~205 (2008)
79. Gecse K, "Increased faecal serine protease activity in diarrhoeic IBS patients: a colonic lumenal factor impairing colonic permeability and sensitivity", Gut, 57, pp.591~599 (2008)
80. Morris KV, "The emerging role of RNA in the regulation of gene transcription in human cells", Semin Cell Dev Biol, 22, pp.351~358 (2011)
81. Khalil AM, "RNA-protein interactions in human health and disease", Semin Cell Dev Biol, 22, pp.359~365 (2011)
82. Costa FF, "Non-coding RNAs, epigenetics and complexity", Gene, 410, pp.9~17 (2008)
83. Bi Y, "MicroRNAs: novel regulators during the immune response", J Cell Physiol, 218, pp.467~472 (2009)
84. Sheedy FJ, "Adding fuel to fire: microRNAs as a new class of mediators of inflammation", Ann Rheum Dis, 67(Suppl 3), pp.iii50~iii55 (2008)
85. Zhou Q, "MicroRNA-29a regulates intestinal membrane permeability in patients with irritable bowel syndrome", Gut, 59, pp.775~784 (2010)
86. Wu F, "MicroRNAs are differentially expressed in ulcerative colitis and alter expression of macrophage inflammatory peptide-2 alpha", Gastroenterology, 135, pp.1624~1635 (2008)
87. Kong WM, "Changes of tight junction claudin-1,-3,-4 protein expression in the intestinal mucosa in patients with irritable bowel syndrome", Nan Fang Yi Ke Da Xue Xue Bao, 27, pp.1345~1347 (2007)

관련 논문AI추천